MHB118C
/ Minghui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2025
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=200 | Recruiting | Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
New P1 trial • Solid Tumor
1 to 1
Of
1
Go to page
1